General
Preferred name
estriol
Synonyms
Oestriol ()
NSC-12169 ()
16.ALPHA.-HYDROXYESTRADIOL ()
Ovestin ()
estriol succinate ()
Theelol ()
Aacifemine ()
Gynest ()
Incurin ()
Trihydroxyestrin ()
Estriol Acetate Benzoate ()
Estriol Propionate ()
16.alpha.,17.beta.-estriol ()
Ortho-Gynest ()
Colpogyn ()
estrogen ()
Estriol-d2 ()
P&D ID
PD009372
CAS
50-27-1
53866-32-3
Tags
probe
natural product
drug
available
Approved by
FDA
Drug Status
investigational
approved
vet_approved
Drug indication
Hormone deficiency
Multiple sclerosis
Max Phase
Phase 4
Probe info
Probe type
calculated probe
Probe sources
Probe targets
[[ compound.targets[t].gene_name ]]
Probe control
Probe control not defined
Orthogonal probes
10
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Estriol (E3) is one of the three main endogenous human estrogens. E3 is only produced in significant amounts during pregnancy, being synthesised in the placenta from 16-hydroxydehydroepiandrosterone sulfate (16-OH DHEAS), an androgen of fetal origin.
(GtoPdb)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
1
Organisms
0
Compound Sets
24
ChEMBL Approved Drugs
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
EU-OPENSCREEN Bioactive Compound Library
Guide to Pharmacology
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
NURSA ligand set
Prestwick Chemical Library
Probe Miner (suitable probes)
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
118
Properties
(calculated by RDKit )
Molecular Weight
288.17
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
3
Rotatable Bonds
0
Ring Count
4
Aromatic Ring Count
1
cLogP
2.58
TPSA
60.69
Fraction CSP3
0.67
Chiral centers
6.0
Largest ring
6.0
QED
0.69
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
Endocrinology/Hormones
Immunology/Inflammation
Metabolic Enzyme/Protease
Vitamin D Related/Nuclear Receptor
Target
ER
MRP1
ESR1, ESR2
Endogenous Metabolite
Estrogen Receptor/ERR
Estrogen/progestogen Receptor
Indication
menopause, vaginal atrophy, urinary tract infections
Disease Area
endocrinology, obstetrics/gynecology, infectious disease
MOA
Estrogen receptor agonist
Therapeutic Class
Estrogens
Source data